Table:
begin	end	state
1	11	cytoplasmic
12	32	transmembrane
33	49	non-cytoplasmic
50	69	transmembrane
70	83	cytoplasmic
84	103	transmembrane
104	109	non-cytoplasmic
110	132	transmembrane
133	143	cytoplasmic
144	165	transmembrane
166	176	non-cytoplasmic
177	199	transmembrane
200	241	cytoplasmic
242	264	transmembrane
265	277	non-cytoplasmic
278	297	transmembrane
298	307	cytoplasmic
308	327	transmembrane
328	333	non-cytoplasmic
334	357	transmembrane
358	367	cytoplasmic
368	394	transmembrane
395	399	non-cytoplasmic
400	419	transmembrane
420	425	cytoplasmic

Input:
>WP_109968169.1 NCBI__GCF_003173355.1:WP_109968169.1
MLVSQESEKRIISLIRLHIIPFALLLYIVAFLDRVNLGYAAIVMNPDLGISAELFGFISG
IFFIGYLIFEVPSNIIMQKVGARIWIGRIMISWGLVAVLMGFVQSPEHLIILRFLLGIAE
AGFFPGMIWYLGTWFPHRYLARSIALFSTAIVISNIIGAPLSMYILDTVNWGSVASWRWL
FIIEGIPAILFGVLSLFILKNRPADAGWLDSDQKQWLVSELESGTIRMKSHRLGDILTDT
RVLLFSGTYFAVTVGMYAIIFFLPTLSSSFLHDLDMRVIGLILMIPYIVTLICMFLVSSH
SDLRGERLYHIIILFFIAGAGLTLDQLAEDPILSLLGITIALSGILSIIGPFWSYVLSVF
TPDEQPVGVAVINSIGNLGGFVGPVITGYLISLFKTLDSGWPVITFILCLGAVMIFMAGK
KGIRM

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server